Provision partners with MTMC, Henry Schein to drive savings to the surgery center community

Provision, Device Reprocessing Solutions is partnering with MedTech/MedCare and Henry Schein to encourage sales and provide support for Provision’s medical device reprocessing solutions.

Advertisement

Here’s what you should know.

1. MTMC’s 70-plus sales executives will support Provision and Henry Schein Medical in selling its medical device reprocessing solutions.

2. Henry Schein’s sales staff will provide surgery centers cost savings opportunities.

3. Provision offers a 50 percent discount pricing model, lead-times between 10 and 14 days as well as several other tools to drive savings to the ASC community.

4. Provision can process devices for numerous specialties including orthopedics, ENT, hand and general surgery. The company offers a full portfolio of remastered single-use devices for the ASC marketplace as well.

More articles on improving performance:
6 trends in medical group CEO compensation — up 7.1% in 2017
American Society of Anesthesiologists survey shows widespread drug shortages harm patient care
ABC urges practices to keep HIPAA compliance on their radar — 4 insights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC News

  • Atlanta-based United Digestive is planning an ASC in Watkinsville, Ga., focusing on organic growth to expand its network. The newly-constructed,…

  • At least 25 ASCs have closed over the past five years, a pattern of attrition driven by financial strain, staffing…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

Advertisement

Comments are closed.